Search / Trial NCT06611852

Efficacy of Combined Interferential Therapy and Electronic Cupping Therapy for Chronic Constipation Management

Launched by MIDDLE EAST UNIVERSITY · Sep 22, 2024

Trial Information

Current as of October 07, 2024

Unknown status

Keywords

Chronic Constipation Interferential Therapy Electronic Cupping Therapy

Description

Objective: The purpose of this study was to assess the effectiveness of a combined treatment regimen that includes interferential therapy and electronic cupping therapy on the symptoms of chronic constipation, as well as gastrointestinal health outcomes. Methods: This study involved 110 patients with chronic constipation, consisting of 60 females and 50 males, ranging in age from 20 to 40 years. Each participant underwent evaluations using Abdominal Ultrasonography and a standardized constipation scoring system. All participants were allocated into three groups; Group (A) received interfer...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * history of Chronic Constipation (CC), as defined by either experiencing two or fewer Complete Spontaneous Bowel Movements (CSBMs) per week for a minimum of 6 consecutive months before the screening visit
  • * Reporting a sensation of incomplete evacuation or straining during at least a quarter of their bowel movements (according to the generally accepted definition of constipation).
  • * Patients must have had CC persisting for more than 6 months, failed to respond to or be intolerant of medical treatment for at least 3 months
  • Exclusion Criteria:
  • * pregnant or lactating women
  • * Chronic Constipation (CC) resulting from anorectal malformations such as colorectal or anal organic lesions, pelvic floor disorders requiring surgical intervention as determined by the investigator (such as rectal prolapse, rectocele, or enterocele)
  • * presence of implanted electronic devices like cardiac pacemakers, defibrillators, cardiac pumps, or spinal stimulators
  • * CC attributable to medications or neurologic, endocrine, or metabolic conditions
  • * prior history of partial colectomy; conditions like megacolon, megarectum, or colonic inertia
  • * skin abnormalities that hinder the placement of electrodes
  • * women lacking adequate contraception (hormonal or intrauterine device).

About Middle East University

Middle East University is a distinguished academic institution dedicated to advancing health sciences through innovative research and clinical trials. Committed to enhancing medical knowledge and improving patient outcomes, the university collaborates with healthcare professionals and industry partners to conduct rigorous studies across various therapeutic areas. With a strong emphasis on ethical standards and scientific integrity, Middle East University aims to contribute meaningful insights to the global medical community, fostering an environment of excellence in research and education.

Locations

October City, Giza, Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0